COVID-19: Panacea Biotec, RDIF to start Sputnik V production in India
RDIF and Panacea have agreed to produce 100 million doses per year of Sputnik V.
Full Article
COVID-19: Panacea Biotec, RDIF to start Sputnik V production in India
DNA
0 shares
1 views
You might like
Related news coverage
-
Panacea to start production of Sputnik V from summer
IndiaTimes
-
RDIF, Panacea Biotec launch production of Sputnik V COVID-19 vaccine in India
newKerala.com
-
COVID-19 vaccine Sputnik V production begins in India, 100 million doses to be produced annually
Zee News
-
RDIF, Panacea Biotec launch production of Sputnik V vaccine in India
IndiaTimes